Aug 5, 2026 04:05PM
Aug 4, 2026 04:05PM
Jul 16, 2026 04:05PM
Jul 1, 2026 04:05PM
Jun 16, 2026 04:00PM
May 28, 2026 07:05AM
May 5, 2026 04:05PM Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update
Apr 28, 2026 09:05AM
Apr 16, 2026 04:05PM
Mar 28, 2026 10:05AM
Mar 28, 2026 10:05AM
Mar 18, 2026 03:39PM
Mar 18, 2026 12:17PM
Mar 18, 2026 10:28AM Truist Securities models $730M peak revenue for Protagonist Therapeutics (PTGX) in Icotyde royalties
Mar 18, 2026 08:05AM
Mar 18, 2026 08:05AM
Mar 2, 2026 06:01AM
Mar 2, 2026 02:00AM
Feb 25, 2026 05:15PM
Feb 25, 2026 04:05PM
Jan 30, 2026 06:47AM Protagonist Therapeutics (PTGX) PT Raised to $117 at H.C. Wainwright
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM
Dec 12, 2025 04:54AM
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM
Nov 6, 2025 04:05PM
Oct 7, 2025 11:00PM Jefferies says this stock offers favorable setup with further upside potential
Aug 7, 2025 04:18AM
Aug 6, 2025 04:05PM
Jun 1, 2025 08:00AM
Mar 3, 2025 01:28PM
Mar 3, 2025 06:46AM
Mar 3, 2025 06:45AM
Feb 21, 2025 07:00AM Protagonist Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Jan 6, 2025 04:05PM
Nov 7, 2024 04:05PM
Apr 16, 2024 09:00AM
Jan 31, 2024 04:09PM
Jan 31, 2024 04:05PM
Apr 4, 2023 05:41PM
Mar 15, 2023 04:01PM Protagonist Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Aug 4, 2022 04:05PM
May 4, 2022 04:05PM
Apr 26, 2022 08:54AM
Apr 13, 2022 05:11PM
Apr 12, 2022 09:00AM
Feb 11, 2022 06:01AM
Nov 4, 2021 07:00AM Protagonist Therapeutics Announces Updated Data from Phase 2 Study of Rusfertide in Polycythemia Vera Selected for Oral Presentations at the ASH 2021 Annual Meeting
Nov 3, 2021 04:05PM

327,780 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All